Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. F /
  3. 9LB.F

LEGEND BIOTECH SP.ADS/2 (9LB F) stock market data APIs

€54.5 2.5(4.8%) as of July 26, 2024
Price chart is built with Anychart

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation operates as a subsidiary of Genscript Biotech Corporation.

LEGEND BIOTECH SP.ADS/2 Financial Data Overview

52
54.5
-
54.5
52
36-69
9 577 M
182 M
343 M
-0.33
0.111
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '9LB',
Type: 'Common Stock',
Name: 'LEGEND BIOTECH SP.ADS/2',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
CUSIP: NULL,
}

LEGEND BIOTECH SP.ADS/2 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 343 M
  • EBITDA -425 375 008
  • Earnings Per Share -2.38
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get LEGEND BIOTECH SP.ADS/2 Earnings via APIs

  • Latest Release 2021-06-30
  • EPS/Forecast -0.34

Get LEGEND BIOTECH SP.ADS/2 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get LEGEND BIOTECH SP.ADS/2 latest news via APIs

Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024

Legend Biotech USA Inc. SOMERSET, N.J., July 26, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced preliminary, una...

Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid

Shares of Legend Biotech LEGN rose 12.1% on Friday following an article issued by StreetInsider.com, which mentioned that the company recently received a takeover bid from an unidentified bidder. The...
Do you have any questions?
support@eodhistoricaldata.com